Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35394487.
- Also identified by DOI 10.1001/jama.2022.4877 and PMC identifier 8994158.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study uses 2 large US health care claims databases (Medicare fee-for-service and the US Food and Drug Administration’s Sentinel System) to examine systemic corticosteroid use among nonhospitalized patients with COVID-19.
Medical subject headings
- Glucocorticoids
- COVID-19 Drug Treatment